Association between Epstein-Bar virus and colorectal cancer: A systematic review and meta-analysis.

This study aimed to investigate the prevalence and any potential association between Epstein-Barr virus (EBV) infection and colorectal cancer (CRC). A systematic literature search was performed by finding relevant cross-sectional and case-control studies from main online databases. Heterogeneity, odds ratio (OR), and corresponding 95% confidence interval (CI) were applied to all studies through meta-analysis and forest plots. The analysis was performed using STATA Software v.14.1. Twenty-three articles were included in the meta-analysis, eight of them were case/control and 15 were cross-sectional. The pooled prevalence of EBV among 1954 CRC patients was 18% (95% CI: 12%–26%; I2 = 93.14%). Furthermore, in geographical regions, the highest and lowest prevalence of EBV was observed in South America 30% (95% CI: 18%–43%) and Africa 0% (95% CI: 0%–5%), respectively. An association was found between EBV infection and CRC [OR = 3.4 (95% CI (1.13–10.27); I2 = 72.3%)]. EBV infection is associated with CRC and can be considered a potential risk factor for the development of CRC. Although the exact molecular mechanism of EBV infection in the development of CRC is still unknown, it seems that latent infection by EBV, intestinal damage, and inflammation can be important factors in the induction of CRC. • The pooled prevalence of EBV among colorectal cancer patients was 18% (95% CI: 12%–26%; I2 = 93.14%). • The highest and lowest prevalence of EBV among colorectal cancer patients was observed in South America 30% (95% CI: 18%–43%) and Africa 0% (95% CI: 0%–5%), respectively. • An association was found between EBV infection and colorectal cancer [OR = 3.4 (95% CI (1.13–10.27); I2 = 72.3%)]. [ABSTRACT FROM AUTHOR]